|
AU2002221080A1
(en)
*
|
2000-12-08 |
2002-06-18 |
Masami Kusaka |
Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparingthe same and use thereof
|
|
JP4160295B2
(ja)
*
|
2000-12-08 |
2008-10-01 |
武田薬品工業株式会社 |
３−ピリジル基を有する置換チアゾール誘導体、その製造法および用途
|
|
US20040147561A1
(en)
*
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
|
EP1628666B1
(en)
*
|
2003-05-14 |
2015-09-23 |
NeuroGenetic Pharmaceuticals, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
|
ES2222827B1
(es)
*
|
2003-07-30 |
2006-03-01 |
Laboratorios Del Dr. Esteve, S.A. |
Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
|
|
EP1682127B1
(en)
*
|
2003-11-14 |
2009-07-29 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
|
|
US7560464B2
(en)
|
2004-04-13 |
2009-07-14 |
Icagen, Inc. |
Polycyclic pyrimidines as potassium ion channel modulators
|
|
JP4602686B2
(ja)
*
|
2004-04-15 |
2010-12-22 |
広栄化学工業株式会社 |
２，６−ジハロゲノ−４−アリールピリジン類の製造法
|
|
WO2006044456A1
(en)
*
|
2004-10-13 |
2006-04-27 |
Ptc Therapeutics, Inc. |
Compounds for nonsense suppression, and methods for their use
|
|
MX2007004781A
(es)
*
|
2004-10-20 |
2007-05-11 |
Applied Research Systems |
Derivados de 3-arilamino piridina.
|
|
WO2006051723A1
(ja)
*
|
2004-11-09 |
2006-05-18 |
Kaneka Corporation |
１－ハロ－３－アリール－２－プロパノン類の製造法
|
|
GB0428514D0
(en)
*
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
|
AU2005325497A1
(en)
*
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Indoles useful in the treatment of inflammation
|
|
KR20080019213A
(ko)
|
2005-05-09 |
2008-03-03 |
아칠리온 파르마세우티칼스 인코포레이티드 |
티아졸 화합물 및 그 사용방법
|
|
KR20080031038A
(ko)
*
|
2005-07-29 |
2008-04-07 |
4에스체 악티엔게젤샤프트 |
신규의 헤테로환 ＮＦ-κＢ 억제제
|
|
FR2889526B1
(fr)
|
2005-08-04 |
2012-02-17 |
Aventis Pharma Sa |
7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
US7947707B2
(en)
*
|
2005-10-07 |
2011-05-24 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
|
|
TWI385169B
(zh)
|
2005-10-31 |
2013-02-11 |
Eisai R&D Man Co Ltd |
經雜環取代之吡啶衍生物及含有彼之抗真菌劑
|
|
CA2635541A1
(en)
*
|
2005-12-28 |
2007-07-12 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
|
|
KR101081293B1
(ko)
|
2006-01-18 |
2011-11-08 |
에프. 호프만-라 로슈 아게 |
11 베타-에이치에스디1 억제제로서 티아졸
|
|
HRP20130058T1
(hr)
|
2006-01-24 |
2013-02-28 |
Eli Lilly & Company |
Indolsulfonamidni modulatori progesteronskih receptora
|
|
CA2646732C
(en)
*
|
2006-03-29 |
2015-04-28 |
F. Hoffmann-La Roche Ag |
Pyridine and pyrimidine derivatives as mglur2 antagonists
|
|
US7649007B2
(en)
|
2006-08-15 |
2010-01-19 |
Wyeth Llc |
Oxazolidine derivatives as PR modulators
|
|
WO2008021338A2
(en)
|
2006-08-15 |
2008-02-21 |
Wyeth |
Tricyclic oxazolidone derivatives useful as pr modulators
|
|
US7538107B2
(en)
|
2006-08-15 |
2009-05-26 |
Wyeth |
Oxazinan-2-one derivatives useful as PR modulators
|
|
WO2008021309A1
(en)
|
2006-08-15 |
2008-02-21 |
Wyeth |
Imidazolidin-2-one derivatives useful as pr modulators
|
|
WO2008035726A1
(en)
|
2006-09-21 |
2008-03-27 |
Eisai R & D Management Co., Ltd. |
Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
|
|
JP5284788B2
(ja)
*
|
2006-09-21 |
2013-09-11 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロアリール環置換ピリジン誘導体およびそれらを含有する抗真菌剤
|
|
JP2010505866A
(ja)
|
2006-10-02 |
2010-02-25 |
コルテンド・インヴェスト・アクチボラゲット |
ヒトにおけるケトコナゾールエナンチオマー
|
|
US8466154B2
(en)
|
2006-10-27 |
2013-06-18 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to wrapping of dehydrons
|
|
US9187485B2
(en)
|
2007-02-02 |
2015-11-17 |
Baylor College Of Medicine |
Methods and compositions for the treatment of cancer and related hyperproliferative disorders
|
|
MX2009012613A
(es)
|
2007-05-22 |
2010-04-21 |
Achillion Pharmaceuticals Inc |
Tiazoles substituidos por heteroarilo y su uso como agentes antivirales.
|
|
EP2786993B1
(en)
|
2007-08-13 |
2017-11-15 |
Monsanto Technology LLC |
Compositions and methods for controlling nematodes
|
|
EP2195312B1
(en)
|
2007-10-09 |
2012-11-21 |
Merck Patent GmbH |
Pyridine derivatives useful as glucokinase activators
|
|
US8513287B2
(en)
|
2007-12-27 |
2013-08-20 |
Eisai R&D Management Co., Ltd. |
Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
|
|
KR20100113557A
(ko)
|
2008-01-11 |
2010-10-21 |
노파르티스 아게 |
키나제 억제제로서의 피리미딘
|
|
WO2009094224A1
(en)
|
2008-01-25 |
2009-07-30 |
Millennium Pharmaceuticals, Inc. |
Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
|
|
WO2009099194A1
(ja)
|
2008-02-08 |
2009-08-13 |
Shiseido Company Ltd. |
美白剤及び皮膚外用剤
|
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
UA105005C2
(uk)
*
|
2008-06-16 |
2014-04-10 |
Юніверсіті Оф Теннессі Рісерч Фаундейшн |
Сполуки для лікування раку
|
|
US9447049B2
(en)
|
2010-03-01 |
2016-09-20 |
University Of Tennessee Research Foundation |
Compounds for treatment of cancer
|
|
US9029408B2
(en)
|
2008-06-16 |
2015-05-12 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
CA2734486A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Southern Research Institute |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
|
AP3272A
(en)
|
2008-09-22 |
2015-05-31 |
Cayman Chem Co |
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prosaglandin D2 mediated diseases
|
|
US9090601B2
(en)
|
2009-01-30 |
2015-07-28 |
Millennium Pharmaceuticals, Inc. |
Thiazole derivatives
|
|
US8796314B2
(en)
|
2009-01-30 |
2014-08-05 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
CA2750935A1
(en)
|
2009-01-30 |
2010-08-12 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and their use as pi3k inhibitors
|
|
WO2010106290A1
(fr)
*
|
2009-03-19 |
2010-09-23 |
Sanofi-Aventis |
Derives d'indazole inhibiteurs d'hsp90, compositions les contenant et utilisation
|
|
WO2011059784A1
(en)
*
|
2009-10-29 |
2011-05-19 |
Bristol-Myers Squibb Company |
Tricyclic heterocyclic compounds
|
|
WO2011051198A2
(de)
*
|
2009-10-30 |
2011-05-05 |
Bayer Cropscience Ag |
Pyridin-derivate als pflanzenschutzmittel
|
|
DE102009058280A1
(de)
*
|
2009-12-14 |
2011-06-16 |
Merck Patent Gmbh |
Thiazolderivate
|
|
EP3064204A1
(en)
|
2010-03-01 |
2016-09-07 |
GTx, Inc. |
Compounds for treatment of cancer
|
|
US8673922B2
(en)
|
2010-07-15 |
2014-03-18 |
Bristol-Myers Squibb Company |
Azaindazole compounds
|
|
KR101926320B1
(ko)
|
2010-08-04 |
2018-12-06 |
펠피큐어 파마슈티걸즈 아이엔씨 |
전립선 암종의 치료를 위한 병용 요법
|
|
WO2012021611A1
(en)
|
2010-08-11 |
2012-02-16 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
JP2013533318A
(ja)
|
2010-08-11 |
2013-08-22 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
ヘテロアリールおよびその使用
|
|
PH12013500274A1
(en)
|
2010-08-11 |
2013-03-04 |
Millennium Pharm Inc |
Heteroaryls and uses thereof
|
|
CA2814688A1
(en)
|
2010-10-13 |
2012-04-19 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
BR112013009823A2
(pt)
|
2010-10-22 |
2016-07-05 |
Bayer Ip Gmbh |
novos compostos heterocíclicos como pesticidas
|
|
AU2011320565A1
(en)
*
|
2010-10-28 |
2013-05-23 |
Innocrin Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
WO2012064815A1
(en)
|
2010-11-12 |
2012-05-18 |
Bristol-Myers Squibb Company |
Substituted azaindazole compounds
|
|
GB2485404A
(en)
*
|
2010-11-15 |
2012-05-16 |
Nat Univ Ireland |
Metal-complexed pyridyl-substituted tetrazole compounds and their use in treating cancer
|
|
CN102675286B
(zh)
*
|
2011-03-07 |
2015-08-19 |
中国科学院上海药物研究所 |
一类吲唑类化合物及其制备方法、用途和药物组合物
|
|
MX359399B
(es)
*
|
2011-04-28 |
2018-09-27 |
Novartis Ag |
Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
|
|
WO2012162468A1
(en)
*
|
2011-05-25 |
2012-11-29 |
Janssen Pharmaceutica Nv |
Thiazol derivatives as pro -matrix metalloproteinase inhibitors
|
|
WO2013049263A1
(en)
|
2011-09-27 |
2013-04-04 |
Bristol-Myers Squibb Company |
Substituted bicyclic heteroaryl compounds
|
|
JP6496246B2
(ja)
*
|
2012-10-05 |
2019-04-03 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
アルドステロンシンターゼインヒビター関連用途としてのインドリン化合物
|
|
US9522141B2
(en)
|
2012-12-20 |
2016-12-20 |
Merck Sharp & Dohme Corp. |
Indazole compounds as aldosterone synthase inhibitors
|
|
EP2964028A4
(en)
|
2013-03-05 |
2017-06-07 |
University of Tennessee Research Foundation |
Compounds for treatment of cancer
|
|
WO2014158875A1
(en)
|
2013-03-14 |
2014-10-02 |
Pellficure Pharmaceuticals Inc. |
Novel therapy for prostate carcinoma
|
|
CA2960750A1
(en)
|
2014-09-12 |
2016-03-17 |
Pellficure Pharmaceuticals, Inc. |
Compositions and methods for treatment of prostate carcinoma
|
|
WO2018080933A1
(en)
|
2016-10-24 |
2018-05-03 |
Pellficure Pharmaceuticals Inc. |
Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
|
|
JP7193071B2
(ja)
*
|
2017-02-08 |
2022-12-20 |
国立大学法人東海国立大学機構 |
蛍光発光材料および紫外線吸収剤
|
|
WO2021126779A1
(en)
*
|
2019-12-18 |
2021-06-24 |
The Regents Of The University Of California |
Inhibitors of lin28 and methods of use thereof
|
|
US20210246109A1
(en)
*
|
2020-02-11 |
2021-08-12 |
University Of Kentucky Research Foundation |
Potent and selective inhibitors of cytochrome p450
|
|
WO2023049199A1
(en)
*
|
2021-09-24 |
2023-03-30 |
Zeno Management, Inc. |
Azole compounds
|
|
CN117551029A
(zh)
*
|
2023-11-22 |
2024-02-13 |
河南大学 |
一种4-溴-3-氰基吡啶的合成方法
|